List of Excipients in Branded Drug CHILDRENS MOTRIN

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Kenvue Brands LLC	CHILDRENS MOTRIN	ibuprofen	50580-184	ACESULFAME POTASSIUM
Kenvue Brands LLC	CHILDRENS MOTRIN	ibuprofen	50580-184	ANHYDROUS CITRIC ACID
Kenvue Brands LLC	CHILDRENS MOTRIN	ibuprofen	50580-184	GLYCERIN
Kenvue Brands LLC	CHILDRENS MOTRIN	ibuprofen	50580-184	POLYSORBATE 80
Kenvue Brands LLC	CHILDRENS MOTRIN	ibuprofen	50580-184	SODIUM BENZOATE
Kenvue Brands LLC	CHILDRENS MOTRIN	ibuprofen	50580-184	SUCROSE
Kenvue Brands LLC	CHILDRENS MOTRIN	ibuprofen	50580-184	WATER

Generic Drugs Containing CHILDRENS MOTRIN

Company	Ingredient	NDC	Excipient
Kenvue Brands LLC	ibuprofen	50580-932	ACESULFAME POTASSIUM
Kenvue Brands LLC	ibuprofen	50580-932	AMMONIUM GLYCYRRHIZATE
Kenvue Brands LLC	ibuprofen	50580-932	ASPARTAME
Kenvue Brands LLC	ibuprofen	50580-932	CARNAUBA WAX
Kenvue Brands LLC	ibuprofen	50580-932	CROSCARMELLOSE SODIUM
Kenvue Brands LLC	ibuprofen	50580-932	HYPROMELLOSE
Kenvue Brands LLC	ibuprofen	50580-932	MAGNESIUM STEARATE

What are the Most Frequently-Used Excipients in CHILDRENS MOTRIN?

# Of NDCs	Excipient
2	ACESULFAME POTASSIUM
2	AMMONIUM GLYCYRRHIZATE
2	ASPARTAME
2	CARNAUBA WAX
2	CROSCARMELLOSE SODIUM
1	D&C RED NO. 27 ALUMINUM LAKE
1	FD&C BLUE NO. 1--ALUMINUM LAKE

Excipient Strategy and Commercial Opportunities for Children’s Motrin

Last updated: March 2, 2026

What are the key excipient considerations for Children’s Motrin?

Children’s Motrin (ibuprofen) formulations require excipients that ensure safety, stability, palatability, and compliance with regulatory standards for pediatric use.

Critical excipients include:

• Sweeteners: Sucrose, high fructose corn syrup, or artificial sweeteners to improve taste.
• Flavoring agents: Natural or artificial flavors to increase palatability.
• Suspending agents: Carboxymethylcellulose (CMC), xanthan gum, or sodium alginate to maintain suspension stability.
• Preservatives: Methylparaben or benzyl alcohol to prevent microbial growth, depending on formulation type.
• Colorants: FD&C or D&C dyes to aid in dose differentiation.
• pH adjusters: Citric acid or sodium citrate to optimize drug stability.

Regulatory considerations:

• Excipients must align with pediatric safety guidelines from FDA and EMA.
• Avoidance of certain preservatives and flavoring agents due to potential toxicity in children.

How do excipient choices impact commercial opportunities?

Flavor and taste masking:

Enhances patient compliance, especially in children and parents. Innovative flavor profiles can differentiate brands.

Suspension stability:

Optimizes shelf life and reduces manufacturing costs. Use of effective suspending agents reduces batch failures and recalls.

Packaging and delivery systems:

Liquid syrups, dissolvable tablets, and dispersible granules require excipients compatible with delivery formats.

Regulatory compliance:

Demonstrating rigorous safety testing of excipients expands market access and diminishes liability, facilitating global commercialization.

Market differentiation:

Proprietary formulations with optimized excipients can command premium pricing and extended patent life.

---

What are emerging opportunities in excipient innovation?

Natural excipients:

Use of plant-derived stabilizers and flavorings align with consumer trends toward clean-label products.

Novel taste-masking technologies:

Microencapsulation and coating techniques improve palatability without excess additives.

Biodegradable suspending agents:

Development of eco-friendly excipients reduces environmental impact.

Smart excipient systems:

Incorporating controlled-release components enables sustained drug release, potentially reducing dosing frequency.

Stability-enhancing excipients:

Innovations that extend shelf life in variable storage conditions open new distribution avenues.

How does the formulation landscape influence market potential?

Aspect	Impact	Opportunity
Pediatric safety standards	Limit excipient choice	Invest in safe excipient research for regulatory approval
Palatability	Increases adherence	Develop flavor profiles tailored for different markets
Shelf stability	Reduces costs	Innovate suspension systems with longer shelf life
Delivery formats	Expands customer base	Create dissolvable tablets or granules for variety

Key regulatory backdrop

• FDA Guidance: Emphasizes excipient safety in pediatric formulations (June 2020 update).
• EMA Pediatric Regulations: Favor formulations with thoroughly evaluated excipients, incentivizing innovation.
• International harmonization efforts aim to create standardized safety profiles for excipients.

Market outlook

The pediatric liquid analgesic market is valued at $1.2 billion globally, with an expected CAGR of 5% over the next five years. Children’s Motrin occupies a significant market share, driven by brand recognition and safety profile.

Manufacturers who innovate excipient strategies to enhance safety, flavor, and stability are positioned for competitive advantage. Intellectual property rights tied to specialized excipient formulations present additional revenue streams through licensing and patenting.

Key takeaways

• Excipient choices in Children’s Motrin impact safety, taste, stability, and regulatory approval.
• Market differentiation hinges on flavor, suspension longevity, and delivery format innovations.
• Emerging trends include natural, biodegradable, and controlled-release excipient systems.
• Compliance with pediatric excipient standards is crucial for global market access.
• Investing in excipient innovation offers opportunities for premium pricing, market share expansion, and patent protection.

FAQs

1. What excipients are most critical for pediatric ibuprofen formulations?
   Sweeteners, flavoring agents, suspending agents, preservatives, and colorants.

2. How does excipient selection influence regulatory approval?
   By ensuring safety, efficacy, and compliance with pediatric-specific guidelines, excipient choices streamline approval processes.

3. What trends are shaping excipient innovation in children’s medications?
   Natural ingredients, taste-masking technologies, environmentally friendly stabilizers, and controlled-release systems.

4. Can excipient patents provide a competitive edge?
   Yes, proprietary formulations involving novel excipients can extend patent life and create licensing opportunities.

5. What regulatory agencies impact excipient strategies for Children’s Motrin?
   FDA, EMA, and international harmonization bodies oversee safety and labeling requirements for pediatric excipients.

---

References

[1] U.S. Food and Drug Administration. (2020). Guidance for Industry: Dosing in Pediatric Populations.
[2] European Medicines Agency. (2019). Reflection Paper on Excipients in Paediatric Formulations.
[3] MarketsandMarkets. (2022). Pediatric Liquid Analgesics Market Analysis.